Concepts (260)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Energy Intake | 14 | 2021 | 83 | 2.830 |
Why?
|
| Sarcopenia | 8 | 2021 | 31 | 2.500 |
Why?
|
| Intensive Care Units | 16 | 2021 | 265 | 2.360 |
Why?
|
| Enteral Nutrition | 13 | 2021 | 62 | 2.320 |
Why?
|
| Parenteral Nutrition | 10 | 2021 | 21 | 2.320 |
Why?
|
| Nutritional Status | 14 | 2021 | 57 | 2.310 |
Why?
|
| Critical Care | 8 | 2021 | 122 | 2.220 |
Why?
|
| Critical Illness | 17 | 2021 | 120 | 2.160 |
Why?
|
| Malnutrition | 9 | 2019 | 24 | 2.150 |
Why?
|
| Nutritional Support | 8 | 2021 | 23 | 1.980 |
Why?
|
| Acute Lung Injury | 6 | 2018 | 18 | 1.640 |
Why?
|
| Dietetics | 5 | 2020 | 9 | 1.530 |
Why?
|
| Body Composition | 6 | 2022 | 69 | 1.530 |
Why?
|
| Hypothyroidism | 3 | 2023 | 69 | 1.220 |
Why?
|
| Respiratory Insufficiency | 6 | 2023 | 53 | 1.090 |
Why?
|
| Nutritional Requirements | 7 | 2021 | 16 | 1.060 |
Why?
|
| Humans | 58 | 2023 | 27307 | 1.020 |
Why?
|
| Respiratory Muscles | 3 | 2021 | 18 | 0.970 |
Why?
|
| Neoplasms | 3 | 2017 | 242 | 0.970 |
Why?
|
| Muscle, Skeletal | 7 | 2021 | 383 | 0.940 |
Why?
|
| Blood Glucose | 6 | 2021 | 108 | 0.930 |
Why?
|
| Tomography, X-Ray Computed | 6 | 2022 | 667 | 0.910 |
Why?
|
| Hand Strength | 2 | 2021 | 58 | 0.860 |
Why?
|
| Male | 37 | 2022 | 14887 | 0.780 |
Why?
|
| Female | 37 | 2022 | 15334 | 0.760 |
Why?
|
| Research Design | 2 | 2021 | 189 | 0.750 |
Why?
|
| Nutrition Assessment | 8 | 2019 | 43 | 0.730 |
Why?
|
| Thyroxine | 4 | 2023 | 81 | 0.710 |
Why?
|
| Nutritionists | 2 | 2020 | 2 | 0.710 |
Why?
|
| C-Reactive Protein | 4 | 2016 | 97 | 0.690 |
Why?
|
| Medical Staff Privileges | 1 | 2020 | 2 | 0.670 |
Why?
|
| Hospitalization | 7 | 2018 | 315 | 0.670 |
Why?
|
| Cachexia | 2 | 2017 | 12 | 0.670 |
Why?
|
| Prescriptions | 1 | 2020 | 17 | 0.660 |
Why?
|
| Adult | 22 | 2023 | 7945 | 0.650 |
Why?
|
| Muscle Strength | 2 | 2019 | 131 | 0.630 |
Why?
|
| Middle Aged | 26 | 2021 | 9068 | 0.620 |
Why?
|
| Organ Dysfunction Scores | 1 | 2019 | 5 | 0.610 |
Why?
|
| Insulin | 4 | 2013 | 91 | 0.610 |
Why?
|
| Cross-Sectional Studies | 7 | 2023 | 903 | 0.610 |
Why?
|
| Triiodothyronine | 3 | 2023 | 92 | 0.580 |
Why?
|
| Underage Drinking | 1 | 2017 | 1 | 0.560 |
Why?
|
| Thyrotropin | 2 | 2020 | 49 | 0.550 |
Why?
|
| Impulsive Behavior | 1 | 2017 | 15 | 0.550 |
Why?
|
| Dietary Proteins | 5 | 2016 | 26 | 0.540 |
Why?
|
| Adolescent Behavior | 1 | 2017 | 25 | 0.540 |
Why?
|
| Personality | 1 | 2017 | 53 | 0.530 |
Why?
|
| Prevalence | 8 | 2021 | 458 | 0.530 |
Why?
|
| Self Report | 1 | 2018 | 225 | 0.530 |
Why?
|
| Smoking | 1 | 2017 | 183 | 0.500 |
Why?
|
| Retrospective Studies | 10 | 2021 | 3551 | 0.490 |
Why?
|
| Patient Satisfaction | 1 | 2018 | 321 | 0.460 |
Why?
|
| Respiration, Artificial | 8 | 2021 | 109 | 0.450 |
Why?
|
| Aged | 20 | 2021 | 9120 | 0.430 |
Why?
|
| Hypoglycemia | 1 | 2013 | 13 | 0.400 |
Why?
|
| Protein-Energy Malnutrition | 1 | 2011 | 3 | 0.370 |
Why?
|
| Prealbumin | 1 | 2011 | 4 | 0.370 |
Why?
|
| APACHE | 6 | 2021 | 27 | 0.360 |
Why?
|
| Monitoring, Physiologic | 1 | 2011 | 70 | 0.350 |
Why?
|
| Eating | 1 | 2010 | 57 | 0.320 |
Why?
|
| Quality of Health Care | 1 | 2010 | 102 | 0.320 |
Why?
|
| Inflammation | 1 | 2011 | 287 | 0.310 |
Why?
|
| Patient Care Team | 1 | 2010 | 119 | 0.310 |
Why?
|
| Body Mass Index | 7 | 2022 | 462 | 0.300 |
Why?
|
| Diet | 1 | 2010 | 219 | 0.290 |
Why?
|
| Adipose Tissue | 2 | 2022 | 76 | 0.280 |
Why?
|
| Practice Guidelines as Topic | 4 | 2017 | 261 | 0.280 |
Why?
|
| Affect | 2 | 2018 | 60 | 0.280 |
Why?
|
| Hospital Mortality | 3 | 2017 | 141 | 0.270 |
Why?
|
| Surveys and Questionnaires | 4 | 2023 | 1156 | 0.260 |
Why?
|
| Hyperglycemia | 4 | 2013 | 30 | 0.250 |
Why?
|
| Combined Modality Therapy | 2 | 2017 | 306 | 0.250 |
Why?
|
| Growth | 1 | 2005 | 6 | 0.240 |
Why?
|
| Child Nutritional Physiological Phenomena | 1 | 2005 | 5 | 0.240 |
Why?
|
| Ketone Bodies | 1 | 2005 | 4 | 0.240 |
Why?
|
| Ketosis | 1 | 2005 | 7 | 0.240 |
Why?
|
| Obesity | 4 | 2016 | 309 | 0.230 |
Why?
|
| Epilepsy | 1 | 2005 | 69 | 0.220 |
Why?
|
| Child Development | 1 | 2005 | 69 | 0.220 |
Why?
|
| Pilot Projects | 3 | 2021 | 415 | 0.220 |
Why?
|
| Depression | 2 | 2018 | 446 | 0.210 |
Why?
|
| Length of Stay | 5 | 2014 | 321 | 0.210 |
Why?
|
| Proportional Hazards Models | 4 | 2017 | 350 | 0.210 |
Why?
|
| Noninvasive Ventilation | 1 | 2023 | 11 | 0.200 |
Why?
|
| Maximal Respiratory Pressures | 2 | 2019 | 3 | 0.200 |
Why?
|
| Academies and Institutes | 2 | 2020 | 11 | 0.200 |
Why?
|
| Inpatients | 2 | 2019 | 125 | 0.200 |
Why?
|
| Postoperative Complications | 2 | 2021 | 930 | 0.200 |
Why?
|
| Risk Factors | 4 | 2021 | 2335 | 0.200 |
Why?
|
| Societies, Medical | 2 | 2020 | 123 | 0.190 |
Why?
|
| Physicians | 2 | 2018 | 126 | 0.190 |
Why?
|
| Respiratory Function Tests | 2 | 2019 | 32 | 0.180 |
Why?
|
| Muscles | 1 | 2021 | 58 | 0.180 |
Why?
|
| Sample Size | 1 | 2021 | 18 | 0.180 |
Why?
|
| Coma | 1 | 2021 | 5 | 0.180 |
Why?
|
| Prospective Studies | 7 | 2020 | 1792 | 0.180 |
Why?
|
| Delirium | 1 | 2021 | 12 | 0.180 |
Why?
|
| Child | 3 | 2018 | 1269 | 0.170 |
Why?
|
| International Classification of Diseases | 2 | 2018 | 13 | 0.170 |
Why?
|
| Superoxide Dismutase | 1 | 2020 | 21 | 0.170 |
Why?
|
| Aged, 80 and over | 7 | 2016 | 4841 | 0.170 |
Why?
|
| Documentation | 2 | 2018 | 23 | 0.170 |
Why?
|
| Intersectoral Collaboration | 1 | 2020 | 6 | 0.170 |
Why?
|
| Euthyroid Sick Syndromes | 1 | 2020 | 7 | 0.170 |
Why?
|
| Long-Term Care | 1 | 2020 | 61 | 0.160 |
Why?
|
| Medicaid | 1 | 2020 | 36 | 0.160 |
Why?
|
| Muscular Atrophy | 2 | 2016 | 12 | 0.160 |
Why?
|
| Cohort Studies | 4 | 2013 | 1903 | 0.160 |
Why?
|
| Medicare | 1 | 2020 | 123 | 0.160 |
Why?
|
| Hospitals | 1 | 2020 | 170 | 0.150 |
Why?
|
| Patients | 1 | 2019 | 33 | 0.150 |
Why?
|
| Overweight | 2 | 2016 | 72 | 0.150 |
Why?
|
| Adolescent | 3 | 2017 | 2185 | 0.150 |
Why?
|
| Child Nutrition Disorders | 1 | 2018 | 1 | 0.150 |
Why?
|
| Clinical Coding | 1 | 2018 | 5 | 0.150 |
Why?
|
| Diagnosis-Related Groups | 1 | 2018 | 8 | 0.150 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2018 | 15 | 0.140 |
Why?
|
| Hormone Replacement Therapy | 1 | 2018 | 35 | 0.140 |
Why?
|
| Thyroid Gland | 1 | 2018 | 43 | 0.140 |
Why?
|
| Professional Competence | 1 | 2018 | 38 | 0.140 |
Why?
|
| Fatigue | 1 | 2018 | 60 | 0.140 |
Why?
|
| Emotions | 1 | 2018 | 72 | 0.140 |
Why?
|
| Puberty | 1 | 2017 | 11 | 0.140 |
Why?
|
| Hospital Costs | 1 | 2018 | 60 | 0.140 |
Why?
|
| Immunomodulation | 1 | 2017 | 8 | 0.140 |
Why?
|
| Patient Compliance | 2 | 2016 | 150 | 0.140 |
Why?
|
| Thrombocytopenia | 1 | 2017 | 22 | 0.140 |
Why?
|
| Child Behavior | 1 | 2017 | 28 | 0.140 |
Why?
|
| Internet | 1 | 2018 | 91 | 0.130 |
Why?
|
| Tomography | 2 | 2013 | 13 | 0.130 |
Why?
|
| Predictive Value of Tests | 2 | 2021 | 478 | 0.130 |
Why?
|
| Thyroid Function Tests | 1 | 2016 | 12 | 0.130 |
Why?
|
| Graft vs Host Disease | 1 | 2017 | 55 | 0.130 |
Why?
|
| Healthy Lifestyle | 1 | 2016 | 45 | 0.130 |
Why?
|
| Electric Impedance | 1 | 2016 | 26 | 0.130 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2018 | 164 | 0.130 |
Why?
|
| Health Surveys | 1 | 2016 | 88 | 0.130 |
Why?
|
| Treatment Outcome | 5 | 2020 | 3540 | 0.130 |
Why?
|
| Quadriceps Muscle | 1 | 2016 | 34 | 0.130 |
Why?
|
| United States | 2 | 2020 | 2078 | 0.130 |
Why?
|
| Point-of-Care Testing | 1 | 2016 | 29 | 0.130 |
Why?
|
| Cystic Fibrosis | 1 | 2016 | 10 | 0.130 |
Why?
|
| Quality of Life | 2 | 2018 | 631 | 0.130 |
Why?
|
| Case-Control Studies | 1 | 2017 | 589 | 0.120 |
Why?
|
| Liver Failure | 1 | 2015 | 10 | 0.120 |
Why?
|
| Advance Care Planning | 1 | 2016 | 13 | 0.120 |
Why?
|
| Dyspnea | 1 | 2016 | 43 | 0.120 |
Why?
|
| MEDLINE | 1 | 2015 | 5 | 0.120 |
Why?
|
| Diagnosis, Differential | 1 | 2016 | 350 | 0.120 |
Why?
|
| Palliative Care | 1 | 2016 | 111 | 0.110 |
Why?
|
| Ultrasonography | 1 | 2016 | 226 | 0.110 |
Why?
|
| Food Hypersensitivity | 1 | 2014 | 45 | 0.110 |
Why?
|
| Comorbidity | 1 | 2015 | 488 | 0.110 |
Why?
|
| Diabetes Mellitus | 2 | 2013 | 130 | 0.110 |
Why?
|
| Chronic Disease | 1 | 2015 | 425 | 0.110 |
Why?
|
| Logistic Models | 3 | 2016 | 398 | 0.110 |
Why?
|
| Longitudinal Studies | 1 | 2017 | 1380 | 0.100 |
Why?
|
| Exercise | 1 | 2016 | 452 | 0.100 |
Why?
|
| Pain | 1 | 2016 | 416 | 0.100 |
Why?
|
| Nutrition Therapy | 1 | 2012 | 6 | 0.100 |
Why?
|
| Nausea | 2 | 2010 | 24 | 0.100 |
Why?
|
| Vomiting | 2 | 2010 | 18 | 0.100 |
Why?
|
| Geriatric Assessment | 1 | 2013 | 209 | 0.090 |
Why?
|
| Health Facilities | 1 | 2011 | 26 | 0.090 |
Why?
|
| Cost Savings | 1 | 2010 | 32 | 0.090 |
Why?
|
| Urban Population | 1 | 2011 | 154 | 0.080 |
Why?
|
| Cost-Benefit Analysis | 1 | 2010 | 126 | 0.080 |
Why?
|
| Anorexia | 1 | 2010 | 3 | 0.080 |
Why?
|
| Body Weight | 2 | 2014 | 135 | 0.080 |
Why?
|
| Liver | 1 | 2011 | 151 | 0.080 |
Why?
|
| Drug Stability | 1 | 2010 | 3 | 0.080 |
Why?
|
| Drug Compounding | 1 | 2010 | 3 | 0.080 |
Why?
|
| Drug Monitoring | 1 | 2010 | 11 | 0.080 |
Why?
|
| Deglutition Disorders | 1 | 2010 | 32 | 0.080 |
Why?
|
| Pharmacy Service, Hospital | 1 | 2010 | 12 | 0.080 |
Why?
|
| Cognition | 1 | 2018 | 1339 | 0.080 |
Why?
|
| Oxidative Stress | 2 | 2020 | 97 | 0.080 |
Why?
|
| Precision Medicine | 1 | 2010 | 28 | 0.080 |
Why?
|
| Administration, Oral | 1 | 2010 | 110 | 0.080 |
Why?
|
| Evidence-Based Medicine | 1 | 2010 | 164 | 0.080 |
Why?
|
| Ventilator Weaning | 1 | 2010 | 35 | 0.080 |
Why?
|
| Guidelines as Topic | 1 | 2010 | 58 | 0.080 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2010 | 291 | 0.080 |
Why?
|
| Chicago | 4 | 2019 | 953 | 0.070 |
Why?
|
| Patient Selection | 1 | 2010 | 197 | 0.070 |
Why?
|
| Biomarkers | 1 | 2011 | 561 | 0.070 |
Why?
|
| Nutritional Sciences | 1 | 2008 | 7 | 0.070 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2008 | 110 | 0.070 |
Why?
|
| Body Height | 1 | 2005 | 35 | 0.060 |
Why?
|
| Nutrition Surveys | 1 | 2023 | 23 | 0.050 |
Why?
|
| Demography | 1 | 2023 | 73 | 0.050 |
Why?
|
| Aging | 1 | 2013 | 1555 | 0.050 |
Why?
|
| Infant | 1 | 2005 | 517 | 0.050 |
Why?
|
| Cannula | 1 | 2023 | 8 | 0.050 |
Why?
|
| Child, Preschool | 1 | 2005 | 624 | 0.050 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2023 | 17 | 0.050 |
Why?
|
| Thyroid Hormones | 1 | 2023 | 58 | 0.050 |
Why?
|
| Oxygen | 1 | 2023 | 66 | 0.050 |
Why?
|
| Radiography, Thoracic | 1 | 2021 | 27 | 0.040 |
Why?
|
| Surgical Procedures, Operative | 1 | 2021 | 29 | 0.040 |
Why?
|
| Glutathione Peroxidase | 1 | 2020 | 4 | 0.040 |
Why?
|
| Hypnotics and Sedatives | 1 | 2021 | 20 | 0.040 |
Why?
|
| Triiodothyronine, Reverse | 1 | 2020 | 9 | 0.040 |
Why?
|
| Follow-Up Studies | 1 | 2005 | 1807 | 0.040 |
Why?
|
| Genotype | 1 | 2020 | 344 | 0.040 |
Why?
|
| Regression Analysis | 1 | 2020 | 258 | 0.040 |
Why?
|
| Young Adult | 2 | 2016 | 2032 | 0.040 |
Why?
|
| Societies | 1 | 2018 | 6 | 0.040 |
Why?
|
| Consensus | 1 | 2018 | 94 | 0.030 |
Why?
|
| Electronic Health Records | 1 | 2018 | 74 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2018 | 133 | 0.030 |
Why?
|
| Injections, Subcutaneous | 2 | 2006 | 22 | 0.030 |
Why?
|
| Cross-Over Studies | 1 | 2016 | 67 | 0.030 |
Why?
|
| Infusions, Intravenous | 2 | 2006 | 52 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2016 | 64 | 0.030 |
Why?
|
| Absorptiometry, Photon | 1 | 2016 | 84 | 0.030 |
Why?
|
| ROC Curve | 1 | 2016 | 141 | 0.030 |
Why?
|
| Terminal Care | 1 | 2016 | 27 | 0.030 |
Why?
|
| Patient Care Planning | 1 | 2016 | 39 | 0.030 |
Why?
|
| Medical Subject Headings | 1 | 2015 | 1 | 0.030 |
Why?
|
| Patient Discharge | 1 | 2016 | 151 | 0.030 |
Why?
|
| Search Engine | 1 | 2015 | 10 | 0.030 |
Why?
|
| Age Distribution | 1 | 2014 | 87 | 0.030 |
Why?
|
| Blood Cell Count | 1 | 2014 | 12 | 0.030 |
Why?
|
| Age of Onset | 1 | 2014 | 95 | 0.030 |
Why?
|
| Chronic Pain | 1 | 2016 | 135 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2016 | 675 | 0.030 |
Why?
|
| Body Fluid Compartments | 1 | 2013 | 5 | 0.030 |
Why?
|
| Intra-Abdominal Fat | 1 | 2013 | 40 | 0.030 |
Why?
|
| Reference Values | 1 | 2013 | 185 | 0.030 |
Why?
|
| Lumbosacral Region | 1 | 2013 | 57 | 0.030 |
Why?
|
| Hospitals, Urban | 1 | 2013 | 34 | 0.030 |
Why?
|
| Minority Groups | 1 | 2013 | 80 | 0.020 |
Why?
|
| Internal Medicine | 1 | 2013 | 31 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2016 | 893 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2013 | 277 | 0.020 |
Why?
|
| Risk | 1 | 2013 | 205 | 0.020 |
Why?
|
| Sepsis | 1 | 2013 | 115 | 0.020 |
Why?
|
| General Surgery | 1 | 2013 | 55 | 0.020 |
Why?
|
| Sex Factors | 1 | 2013 | 469 | 0.020 |
Why?
|
| Quality Improvement | 1 | 2013 | 140 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2013 | 486 | 0.020 |
Why?
|
| Medical Staff, Hospital | 1 | 2008 | 17 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2008 | 139 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2008 | 258 | 0.020 |
Why?
|
| Insulin Glargine | 1 | 2006 | 2 | 0.020 |
Why?
|
| Insulin, Long-Acting | 1 | 2006 | 2 | 0.020 |
Why?
|
| Insulin Infusion Systems | 1 | 2006 | 3 | 0.020 |
Why?
|
| Management Service Organizations | 1 | 2006 | 1 | 0.020 |
Why?
|
| Hypoglycemic Agents | 1 | 2006 | 37 | 0.020 |
Why?
|
| Attitude of Health Personnel | 1 | 2008 | 146 | 0.020 |
Why?
|
| Diabetes Complications | 1 | 2006 | 57 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2006 | 331 | 0.020 |
Why?
|
| Clinical Competence | 1 | 2008 | 210 | 0.020 |
Why?
|
| Internship and Residency | 1 | 2008 | 215 | 0.010 |
Why?
|
| Gastrointestinal Contents | 1 | 2004 | 2 | 0.010 |
Why?
|
| Gastric Emptying | 1 | 2004 | 12 | 0.010 |
Why?
|
| Sampling Studies | 1 | 2004 | 30 | 0.010 |
Why?
|
| Algorithms | 1 | 2006 | 352 | 0.010 |
Why?
|
| Diarrhea | 1 | 2004 | 37 | 0.010 |
Why?
|